HIV and Women: What CDC Is Doing
CDC is pursuing a high-impact HIV prevention approach to maximize the effectiveness of HIV prevention interventions and strategies. Funding state, territorial, and local health departments and community-based organizations (CBOs) to develop and implement tailored programs is CDC’s largest investment in HIV prevention. This includes longstanding successful programs and new efforts funded through the Ending the HIV Epidemic in the U.S. initiative. In addition to funding health departments and CBOs, CDC is also strengthening the HIV prevention workforce and developing HIV communication resources for consumers and health care providers.
- Under the integrated HIV surveillance and prevention cooperative agreement, CDC awards around $400 million per year to health departments for HIV data collection and prevention efforts. This award directs resources to the populations and geographic areas of greatest need, while supporting core HIV surveillance and prevention efforts across the US.
- In 2019, CDC awarded $12 million to support the development of state and local Ending the HIV Epidemic in the U.S. plans in the nation’s 57 priority areas. To further enhance capacity building efforts, CDC uses HIV prevention resources to fund the National Alliance of State and Territorial AIDS Directors (NASTAD) with $1.5 million per year to support strategic partnerships, community engagement, peer-to-peer technical assistance, and planning efforts.
- In 2020, CDC awarded $109 million to 32 state and local health departments that represent the 57 jurisdictions across the United States prioritized in the Ending the HIV Epidemic in the U.S. This award supports the implementation of state and local Ending the HIV Epidemic in the U.S. plans.
- Under the cooperative agreement for CBOs, CDC awards about $42 million per year to 96 CBOs to implement program components that align with key strategies of the Ending the HIV Epidemic in the U.S. initiative. This award supports the development of new, and enhancement of existing strategies focused on populations disproportionately affected by HIV.
- In 2019, CDC awarded a cooperative agreement to strengthen the capacity and improve the performance of the nation’s HIV prevention workforce. New elements include dedicated providers for web-based and classroom-based national training, and technical assistance tailored within four geographic regions.
- CDC’s Prevention Research Synthesis (PRS) Project identifies evidence-based interventions and best practices through ongoing systematic reviews. The PRS Project has identified several interventions for women in its Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention:
- Through its Let’s Stop HIV Together campaign, CDC offers resources about HIV stigma, testing, prevention, and treatment and care. This campaign is part of the Ending the HIV Epidemic in the U.S. initiative.
- To raise awareness about the impact of HIV on women and to show support for women with HIV, CDC promotes National Women and Girls HIV/AIDS Awareness Day (March 10). This awareness day is sponsored by the U.S. Department of Health and Human Services, Office on Women’s Health.
- CDC’s Office of Women’s Health promotes public health research, evidence-based programs, policies, and strategies to improve the health and well-being of women and girls.
- CDC. Behavioral and clinical characteristics of persons with diagnosed HIV infection—Medical Monitoring Project, United States, 2020 cycle (June 2020–May 2021). HIV Surveillance Special Report 2022;29.
- CDC. Diagnoses of HIV infection in the United States and dependent areas, 2019. HIV Surveillance Report 2021;32.
- CDC. Estimated HIV incidence and prevalence in the United States, 2015-2019 [PDF – 3 MB]. HIV Surveillance Supplemental Report 2021;26(1).
- CDC. HIV infection risk, prevention, and testing behaviors among heterosexually active adults at increased risk for HIV infection–National HIV Behavioral Surveillance – 23 U.S. Cities, 2019 [PDF – 3 MB]. HIV Surveillance Special Report 2021; 26.
- CDC. HIV infection risk, prevention, and testing behaviors among persons who inject drugs–National HIV Behavioral Surveillance: injection drug use – 23 U.S. Cities, 2018 [PDF – 2 MB]. HIV Surveillance Special Report 2020; 24.
- CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021;26(2).